Cell Reprogramming Services: Great Potential in Clinical and Medical Application

January 20 19:12 2021
In recent days, Creative Bioarray announced the release of its cell reprogramming services with cutting-edge technologies in order to accelerate drug development.

New York, USA – January 19, 2021 – Creative Bioarray, as a leading customer-focused biotechnology company, is committed to providing global scientists with a wide range of cell culture related products and comprehensive cell-based services that can be applied to speed up the research and development progress in the field of biological and chemical. In recent days, Creative Bioarray announced the release of its cell reprogramming services with cutting-edge technologies in order to accelerate drug development.

The main techniques used for cell reprogramming include transcription factor transduction, cell fusion, in vitro culture, nuclear transfer, and introduction of egg extracts. They are feasible for reprogramming and epigenetic research. Variables that may affect cell reprogramming include the choice of initial cell type, the choice of reprogramming factors, culture conditions and delivery methods. By using various small molecules and growth factors, or manipulating the cell environment, the reprogrammed iPSC can be guided to different differentiation pathways. From wound healing to the treatment of complex diseases, cell reprogramming provides multiple opportunities in clinical applications. Cell reprogramming has great potential in new medical applications, such as cell replacement therapy and tissue engineering. In the future, iPSC may provide unlimited replacement cells and tissues for patients with currently incurable diseases.

Creative Bioarray can provide different cell reprogramming methods for different cell types and purposes. The reprogrammed cells will be fully identified and fully cryopreserved. Specific supported services include:

Genetic cell reprogramming. The rapid development of gene manipulation technologies, such as viral vectors, additional plasmid vectors, piggyBac transposons, mRNA and miRNA-based reprogramming, protein-based methods, and CRISPR technology, can be used to provide a certain combination of reprogramming factors or to facilitate genome editing.

Reprogramming induced by cell fusion, which is a useful technique for cell reprogramming. By fusing with pluripotent cells, somatic cells can be reprogrammed to a pluripotent state. Chemical modification, virus mediation and electric shock are commonly used methods. Cell fusion is an effective method and an important tool to study the mechanism of reprogramming.

Chemical reprogramming. Several chemical compounds can reprogram one somatic cell type into another desired cell type, such as glial cells, neuronal cells, and cardiomyocytes. This virus- and cancer-free method has almost no effect on genome integrity and cell function, and is an ideal method to further reduce the risk of tumors.

“Creative Bioarray can provide customized cell reprogramming services with fast turnaround time and competitive prices. We can also conduct follow-up experiments according to your requirements.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “Special media for cell reprogramming can also be customized in Creative Bioarray.”

About Creative Bioarray

As a leading customer-focused biotechnology company based in New York, Creative Bioarray is capable to provide biological and chemical products, and strive for solutions that can improve research outcomes and dramatically speed up the research and development progress. With years of efforts, Creative Bioarray has become one of the world’s top suppliers with innovative high-quality products and services related to cell culture.

Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Phone: 1-631-386-8241
Country: United States
Website: https://cell.creative-bioarray.com